SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001437749-18-000841
Filing Date
2018-01-19
Accepted
2018-01-19 16:03:17
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B4 dffn20180118_424b4.htm 424B4 660091
2 a2.jpg GRAPHIC 17783
3 a1.jpg GRAPHIC 24083
4 logo.jpg GRAPHIC 10424
  Complete submission text file 0001437749-18-000841.txt   733694
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-222203 | Film No.: 18537407
SIC: 2834 Pharmaceutical Preparations